BioLife Free Cash Flow Yield from 2010 to 2025

BLFS Stock  USD 21.52  0.22  1.01%   
BioLife Solutions Free Cash Flow Yield yearly trend continues to be comparatively stable with very little volatility. Free Cash Flow Yield is likely to outpace its year average in 2025. Free Cash Flow Yield is a financial solvency ratio that compares the free cash flow per share BioLife Solutions is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. View All Fundamentals
 
Free Cash Flow Yield  
First Reported
2010-12-31
Previous Quarter
0.00435153
Current Value
0.004569
Quarterly Volatility
0.11548703
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as Interest Expense of 755 K, Selling General Administrative of 38.5 M or Total Revenue of 86.4 M, as well as many indicators such as Price To Sales Ratio of 13.81, Dividend Yield of 0.0014 or PTB Ratio of 3.26. BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
  
Build AI portfolio with BioLife Stock
Check out the analysis of BioLife Solutions Correlation against competitors.
For more information on how to buy BioLife Stock please use our How to Invest in BioLife Solutions guide.

Latest BioLife Solutions' Free Cash Flow Yield Growth Pattern

Below is the plot of the Free Cash Flow Yield of BioLife Solutions over the last few years. It is a financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share. BioLife Solutions' Free Cash Flow Yield historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BioLife Solutions' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Yield10 Years Trend
Slightly volatile
   Free Cash Flow Yield   
       Timeline  

BioLife Free Cash Flow Yield Regression Statistics

Arithmetic Mean(0.07)
Geometric Mean0.02
Coefficient Of Variation(170.62)
Mean Deviation0.09
Median(0.01)
Standard Deviation0.12
Sample Variance0.01
Range0.3204
R-Value0.44
Mean Square Error0.01
R-Squared0.20
Significance0.09
Slope0.01
Total Sum of Squares0.20

BioLife Free Cash Flow Yield History

2025 0.004569
2024 0.004352
2023 -0.0266
2022 -0.0244
2021 -0.009213
2020 0.001728
2019 0.001709

About BioLife Solutions Financial Statements

BioLife Solutions shareholders use historical fundamental indicators, such as Free Cash Flow Yield, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.